Jim LimManaging General Partner
Jim joined Greenspring Associates in 2004. Previously, he was a Director at Commonfund Capital, a fund-of-funds firm that, as of the time of his departure, managed nearly $5.5 billion in commitments across venture capital, private equity, international private capital and natural resources programs. While at Commonfund Capital, Jim helped lead the due diligence efforts on many of the firm’s top-tier venture capital managers. He also spent three years at Pfizer where he was primarily responsible for managing the private capital portfolio of the company’s $2.5 billion pension plan. On behalf of the pension plan, Jim made commitments to funds managed by some of the leading venture capital and buyout managers in the industry. In addition to his pension fund experience, Jim had several corporate finance assignments in Pfizer’s Research and Development Group and Pfizer’s Operational, Planning and Analysis Group.
Jim is a cum laude graduate of Washington College where he received his degree in Economics and a graduate of Indiana University, where he received his MBA in Finance. Jim serves on the limited partner boards of Bullpen Capital, Columbia Capital, Fairhaven Capital, Foundry Group, Goodwater Capital, High Alpha Seed Fund, Lead Edge Capital, Lightspeed China, Meritech Capital Partners, OpenView Venture Partners, Peak Equity, Redpoint Ventures and Silversmith Capital. He also currently serves on the board of Kareo and is a board observer of Exinda. He is a former board observer of ExactTarget, PCI Services, Workfront, BARRX Medical and SkinMedica.